A2A Adenosine Receptor Regulates the Human Blood-Brain Barrier Permeability

Molecular Neurobiology

Volumn 52, Issue 1, 2015, Pages 664-678

  Kim, Do Geun ^a   Bynoe, Margaret S ^a  

^a Department of Obstetrics Gynecology   (United States)

Author keywords

A2A adenosine receptor; Blood brain barrier; Paracellular permeability; Rho GTPase; Tight and adherens junctions

Indexed keywords

ADENOSINE A2A RECEPTOR; CLAUDIN 5; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; VASCULAR ENDOTHELIAL CADHERIN; ADENOSINE A2 RECEPTOR; ADENOSINE A2 RECEPTOR AGONIST; ANTINEOPLASTIC AGENT; DEOXYCYTIDINE; GEMCITABINE;

ACTIN FILAMENT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DOWN REGULATION; DRUG DELIVERY SYSTEM; ENDOTHELIUM CELL; HOMEOSTASIS; HUMAN; HUMAN CELL; IN VITRO STUDY; LYMPHOCYTE MIGRATION; MOUSE; NEUROLOGIC DISEASE; NEUROPROTECTION; NONHUMAN; SIGNAL TRANSDUCTION; T LYMPHOCYTE; VASCULARIZATION; ADHERENS JUNCTION; ANALOGS AND DERIVATIVES; ANIMAL; C57BL MOUSE; CELL DEATH; CELL LINE; CELL MEMBRANE PERMEABILITY; CELL MOTION; CYTOLOGY; DRUG EFFECTS; ENZYMOLOGY; FOCAL ADHESION; GLIOBLASTOMA; IMPEDANCE; JURKAT CELL LINE; METABOLISM; PATHOLOGY; PHOSPHORYLATION; STRESS FIBER; TIGHT JUNCTION;

ADENOSINE A2 RECEPTOR AGONISTS; ADHERENS JUNCTIONS; ANIMALS; ANTINEOPLASTIC AGENTS; BLOOD-BRAIN BARRIER; CELL DEATH; CELL LINE; CELL MEMBRANE PERMEABILITY; CELL MOVEMENT; DEOXYCYTIDINE; DOWN-REGULATION; ELECTRIC IMPEDANCE; ENDOTHELIAL CELLS; FOCAL ADHESIONS; GLIOBLASTOMA; HUMANS; JURKAT CELLS; MICE, INBRED C57BL; PHOSPHORYLATION; RECEPTORS, ADENOSINE A2; RHOA GTP-BINDING PROTEIN; SIGNAL TRANSDUCTION; STRESS FIBERS; T-LYMPHOCYTES; TIGHT JUNCTIONS;

EID: 84937977564     PISSN: 08937648     EISSN: 15591182     Source Type: Journal    
DOI: 10.1007/s12035-014-8879-2     Document Type: Article

References (32)

1. Deeken JF, Loscher W (2007) The blood-brain barrier and cancer: transporters, treatment, and Trojan horses. Clin Cancer Res 13:1663–1674
2. Abbott NJ, Ronnback L, Hansson E (2006) Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci 7:41–53. doi:10.1038/nrn1824
3. Giacomini KM (2010) Membrane transporters in drug development. Nat Rev Drug Discov 9:215–236. doi:10.1038/nrd3028
4. Pardridge WM (2005) The blood-brain barrier: bottleneck in brain drug development. NeuroRx 2:3–14
5. Ribatti D, Nico B, Crivellato E, Artico M (2006) Development of the blood-brain barrier: a historical point of view. Anat Rec B New Anat 289:3–8
6. Hossain S, Akaike T, Chowdhury EH (2010) Current approaches for drug delivery to central nervous system. Curr Drug Deliv 7:389–397
7. Blackburn MR, Vance CO, Morschl E, Wilson CN (2009) Adenosine receptors and inflammation Handb Exp Pharmacol:215-269 doi:10.1007/978-3-540-89615-9_8
8. Hasko G, Linden J, Cronstein B, Pacher P (2008) Adenosine receptors: therapeutic aspects for inflammatory and immune diseases. Nat Rev Drug Discov 7:759–770. doi:10.1038/nrd2638
9. Jacobson KA, Gao ZG (2006) Adenosine receptors as therapeutic targets. Nat Rev Drug Discov 5:247–264
10. Fredholm BB APIJ, Jacobson KA, Linden J, Muller CE (2011) International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and classification of adenosine receptors—an update. Pharmacol Rev 63:1–34. doi:10.1124/pr.110.003285
11. Carman AJ, Mills JH, Krenz A, Kim DG, Bynoe MS (2011) Adenosine receptor signaling modulates permeability of the blood-brain barrier. J Neurosci 31:13272–13280. doi:10.1523/JNEUROSCI.3337-11.2011
12. Mills JH, Alabanza L, Weksler BB, Couraud PO, Romero IA, Bynoe MS (2011) Human brain endothelial cells are responsive to adenosine receptor activation. Purinergic Signal 7:265–273. doi:10.1007/s11302-011-9222-2
13. Mills JH et al (2008) CD73 is required for efficient entry of lymphocytes into the central nervous system during experimental autoimmune encephalomyelitis. Proc Natl Acad Sci U S A 105:9325–9330. doi:10.1073/pnas.0711175105
14. Sohail MA et al (2009) Adenosine induces loss of actin stress fibers and inhibits contraction in hepatic stellate cells via Rho inhibition. Hepatology 49:185–194. doi:10.1002/hep.22589
15. Pollard TD, Cooper JA (2009) Actin, a central player in cell shape and movement science. Science 326:1208–1212. doi:10.1126/science.1175862
16. Spindler V, Schlegel N, Waschke J (2010) Role of GTPases in control of microvascular permeability. Cardiovasc Res 87:243–253
17. Li G et al (2010) Permeability of endothelial and astrocyte cocultures: in vitro blood-brain barrier models for drug delivery studies. Ann Biomed Eng 38:2499–2511
18. Carman CV, Springer TA (2008) Trans-cellular migration: cell-cell contacts get intimate. Curr Opin Cell Biol 20:533–540. doi:10.1016/j.ceb.2008.05.007
19. Wolburg H, Wolburg-Buchholz K, Engelhardt B (2005) Diapedesis of mononuclear cells across cerebral venules during experimental autoimmune encephalomyelitis leaves tight junctions intact. Acta Neuropathol 109:181–190. doi:10.1007/s00401-004-0928-x
20. Adamson RH (2002) Rho and rho kinase modulation of barrier properties: cultured endothelial cells and intact microvessels of rats and mice. J Physiol 539:295–308
21. Jaffe AB, Hall A (2005) Rho GTPases: biochemistry and biology. Annu Rev Cell Dev Biol 21:247–269. doi:10.1146/annurev.cellbio.21.020604.150721
22. Riento K, Ridley AJ (2003) Rocks: multifunctional kinases in cell behaviour. Nat Rev Mol Cell Biol 4:446–456. doi:10.1038/nrm1128
23. Tominaga T, Sahai E, Chardin P, McCormick F, Courtneidge SA, Alberts AS (2000) Diaphanous-related formins bridge Rho GTPase and Src tyrosine kinase signaling. Mol Cell
24. Rex CS, Chen LY, Sharma A, Liu J, Babayan AH, Gall CM, Lynch G (2009) Different Rho GTPase-dependent signaling pathways initiate sequential steps in the consolidation of long-term potentiation. J Cell Biol 186:85–97. doi:10.1083/jcb.200901084
25. Jeyaraj SC (2012) Cyclic AMP-Rap1A signaling activates RhoA to induce alpha(2c)-adrenoceptor translocation to the cell surface of microvascular smooth muscle cells. Am J Physiol Cell Physiol 303:C499–511. doi:10.1152/ajpcell.00461.2011
26. Bretscher A, Edwards K, Fehon RG (2002) ERM proteins and merlin: integrators at the cell cortex. Nat Rev Mol Cell Biol 3:586–599. doi:10.1038/nrm882
27. Wu MH (2005) Endothelial focal adhesions and barrier function. J Physiol 569:359–366. doi:10.1113/jphysiol.2005.096537
28. Stevenson BR, Keon BH (1998) The tight junction: morphology to molecules. Annu Rev Cell Dev Biol 14:89–109. doi:10.1146/annurev.cellbio.14.1.89
29. Hordijk PL, Anthony E, Mul FP, Rientsma R, Oomen LC, Roos D (1999) Vascular-endothelial-cadherin modulates endothelial monolayer permeability. J Cell Sci 112(Pt 12):1915–1923
30. Millan J (2010) Adherens junctions connect stress fibres between adjacent endothelial cells. BMC Biol 8:11. doi:10.1186/1741-7007-8-11
31. Adamson C, Kanu OO, Mehta AI, Di C, Lin N, Mattox AK, Bigner DD (2009) Glioblastoma multiforme: a review of where we have been and where we are going. Expert Opin Investig Drugs 18:1061–1083. doi:10.1517/13543780903052764
32. Wojciak-Stothard B, Ridley AJ (2002) Rho GTPases and the regulation of endothelial permeability. Vascul Pharmacol 39:187–199